Recent trends in the treatment of well-differentiated endocrine carcinoma of the small bowel

Figure 1 Management algorithm for patients with non metastatic well-differentiated endocrine carcinoma of the small bowel (stage I-III of TNM classification). 5HIAA: 5-hydroxyindoleacetic acid.

Figure 2 Management algorithm for patients with metastatic well-differentiated endocrine carcinoma of the small bowel (stage IV of TNM classification). TAE: Transarterial embolization; TACE: Transarterial chemoembolization; RFA: Radiofrequency ablation; mTOR: Mammalian target of rapamycin; CT: Computed tomography; MRI: Magnetic resonance imaging.